International Guideline concordance of empiric antibiotic use in community-acquired pneumonia

S. Pascual Guardia (Barcelona, Spain), J. Marin-Corral (Barcelona, Spain), M. Carugati (Milano, Italy), S. Aliberti (Milano, Italy), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A Coruña, Spain), M. Kolditz (Dresden, Germany), M. Restrepo (San Antonio. On behalf of GLIMP investigators., United States of America)

Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Session: Antibiotic therapy for pneumonia and pleural infections
Session type: Oral Presentation
Number: 4669
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Pascual Guardia (Barcelona, Spain), J. Marin-Corral (Barcelona, Spain), M. Carugati (Milano, Italy), S. Aliberti (Milano, Italy), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A Coruña, Spain), M. Kolditz (Dresden, Germany), M. Restrepo (San Antonio. On behalf of GLIMP investigators., United States of America). International Guideline concordance of empiric antibiotic use in community-acquired pneumonia. 4669

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adherence to guidelines and clinical stability in community-acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004

Impact of guidelines on HAP and VAP outcomes
Source: Eur Respir Mon 2011; 53: 66-73
Year: 2011


Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
Source: Eur Respir J 2008; 32: 892-901
Year: 2008



International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Guideline 2017
Year: 2017

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017
Year: 2017



Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP)
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Safety and efficacy of CURB65 guided antibiotic therapy in community-acquired pneumonia
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010


Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia
Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Year: 2003


Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011



Validation of the ATS/IDSA guidelines for ICU-acquired pneumonia
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009


Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia
Source: Eur Respir J, 50 (3) 1602306; 10.1183/13993003.02306-2016
Year: 2017



Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: Guideline 2018
Year: 2019

Empirical treatment of community-acquired pneumonia after outpatient beta-lactam therapy
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018
Year: 2018



Use of diagnostic tests and antibiotics in community-acquired pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 639s
Year: 2005

Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2010; 36: 128-134
Year: 2010



Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Source: Eur Respir J 2003 Dec 01;22(6):876-882
Year: 2003



Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


The approach to antibiotic treatment in community-acquired pneumonia
Source: Annual Congress 2008 - MP14 - The approach to antibiotic treatment in community-acquired pneumonia
Year: 2008